Company / Operating Margin
Emergent BioSolutions Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
13.5%
FY2025
5-year range
-69.2% / 19.3%
FY2021-FY2025
Trend
+229.3%
vs FY2024
Sector context
#34 of 136
Health Care
What the data says
Operating Margin changed +229% YoY in FY2025, a notable deviation from the 9-year average annual change of -15%.
Based on SEC 10-K filings.
13.5% in FY2025 with a 5-year CAGR of -14.4%. Top quartile in the Health Care sector.
Improved from -69.2% to 13.5% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +28.7pp
- 5-Year Change
- -14.4pp
- 10-Year Change
- -
Sector benchmark
Top 25% in Health CareTop 25% of 136This company 13.5% Sector average -778.9%
▼
+101.7% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 229.3% year-over-year.
- Currently 792.4pp above the Health Care sector average.
- Peak operating margin was recorded in FY2020.
- Lowest operating margin in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 13.5% | +229.3% |
| FY2024 | -10.4% | +84.9% |
| FY2023 | -69.2% | -355.2% |
| FY2022 | -15.2% | -179.0% |
| FY2021 | 19.3% | -31.0% |
| FY2020 | 27.9% | +170.3% |
| FY2019 | 10.3% | -52.2% |
| FY2018 | 21.6% | -2.6% |
| FY2017 | 22.2% | +2.7% |
| FY2016 | 21.6% | -20.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026